Hypertrophic Cardiomyopathy

TL;DR. Hypertrophic cardiomyopathy is a common, often genetic heart disease in cats (and occasionally dogs) where the heart muscle thickens abnormally, potentially leading to heart failure or life-threatening blood clots.

In hypertrophic cardiomyopathy, the muscular wall of the left ventricle becomes abnormally thick, reducing the space available for blood.

What is it?

Hypertrophic cardiomyopathy (HCM) is the most common heart disease diagnosed in domestic cats, and it occasionally affects dogs. In pets with HCM, the muscular walls of the left ventricle—the heart's primary pumping chamber—become abnormally thick. This thickening is not caused by another systemic or metabolic disease, such as high blood pressure or an overactive thyroid. Instead, it is a primary disease of the heart muscle itself.

As the muscle wall thickens, the internal volume of the left ventricle decreases. This means the chamber holds less blood than a normal heart. Furthermore, the thickened muscle becomes stiff and cannot relax properly between beats. This inability to relax is known as diastolic dysfunction. Because the heart cannot relax to fill with blood, pressure builds up inside the chamber. This pressure backs up into the left atrium (the receiving chamber) and eventually into the blood vessels of the lungs, leading to fluid accumulation.

Over time, this fluid backup causes congestive heart failure (CHF). Additionally, the turbulent blood flow and enlargement of the left atrium create an environment where blood clots can easily form. If a clot dislodges, it can travel through the bloodstream and block major arteries, a condition known as arterial thromboembolism. Understanding this disease is vital for pet owners, as HCM can remain silent for years before causing sudden, severe illness.

As noted in a leading veterinary internal medicine reference:

"Myocardial disease in cats encompasses a diverse collection of idiopathic and secondary processes affecting the myocardium. The spectrum of anatomic and pathophysiologic features is wide. Disease characterized by myocardial hypertrophy is most common, although features of multiple pathophysiologic categories coexist in some cats."

Causes & risk factors

In the vast majority of cases, hypertrophic cardiomyopathy is an inherited genetic condition. Specific genetic mutations have been identified in certain breeds, which cause the heart muscle fibers to develop abnormally and thicken over time.

While cats are by far the most frequently affected species, the disease is also documented in dogs and even exotic pets like rabbits. However, because canine and rabbit cases are relatively rare, much of the clinical guidance and understanding for these species is extrapolated from feline medicine.

Several breeds are highly predisposed to developing HCM:

• Maine Coon: Possesses a known autosomal dominant genetic mutation.
• Ragdoll: Possesses a known autosomal dominant genetic mutation.
• American Shorthair: Strong evidence of an autosomal dominant genetic pattern.
• Persian, British Shorthair, Norwegian Forest Cat, Scottish Fold, and Bengal Cat: Suspected hereditary predisposition.
• Rex Rabbit: Suspected hereditary predisposition (extrapolated guidance).
• Bengal Terrier and Rex Dog: Suspected hereditary predisposition.

In Maine Coons and Ragdolls, genetic mutations in the cardiac myosin binding protein C gene have been identified. However, genetics in these breeds are complex, as explained by a standard veterinary internal medicine textbook:

"Two mutations in the cardiac myosin binding protein C gene have been found, one in Maine Coon cats and one in Ragdoll cats with HCM. However, other mutations are likely involved because not all Maine Coon cats with evidence for HCM have the identified mutation, and not all cats with the mutation develop HCM."

Signs to watch for

HCM is often called a "silent killer" because many pets show no outward signs of illness until the disease has reached an advanced stage. When symptoms do appear, they are often related to congestive heart failure or blood clots.

Common Signs

• Dyspnea (Labored or rapid breathing): Your pet may breathe with increased effort, use their abdomen to help push air out, or breathe at a rate faster than 30 to 40 breaths per minute while resting.
• Systolic Murmur: Your vet may detect an abnormal whooshing sound during a routine physical exam, caused by turbulent blood flow in the heart.
• Tachycardia: An abnormally fast heart rate, even when the pet is at rest.
• Pulmonary Edema: Fluid accumulation within the lung tissue, which causes coughing (more common in dogs than cats) and severe respiratory distress.
• Pleural Effusion: Fluid accumulation in the chest cavity outside the lungs, which compresses the lungs and makes breathing extremely difficult.
• Congestive Heart Failure: A clinical state where the heart can no longer pump blood efficiently, leading to fluid backup and severe lethargy.

Occasional Signs

• Thromboembolism (Blood Clots): A sudden, excruciatingly painful blockage of blood flow, most commonly to the hind limbs (saddle thrombus). This causes sudden paralysis of the back legs, cold paw pads, and a lack of pulses in the rear limbs.
• Arrhythmias: Irregular heartbeats that can cause sudden weakness, fainting spells (syncope), or sudden death.

Open-mouth breathing and an extended neck are critical signs of respiratory distress in cats and require immediate veterinary attention.

How vets diagnose it

Diagnosing HCM begins with a thorough physical examination. Your vet will listen closely to your pet's heart and lungs to check for murmurs, abnormal heart rhythms (such as a gallop rhythm), or muffled lung sounds that might suggest fluid accumulation. However, a physical exam alone cannot confirm HCM, as some affected pets do not have murmurs, and some pets with murmurs have healthy hearts.

To confirm a diagnosis and assess the severity of the disease, your vet will recommend several diagnostic tests:

• Echocardiography (Gold Standard): This is an ultrasound of the heart and is the only way to definitively diagnose HCM. It allows a veterinary cardiologist or trained clinician to view the heart in real-time, measure the thickness of the chamber walls, assess the size of the left atrium, and evaluate how well the heart muscle relaxes and contracts.
• Thoracic Radiographs (Chest X-rays): X-rays are essential for evaluating the lungs and chest cavity. They allow your vet to see if the heart is enlarged and to detect the presence of pulmonary edema or pleural effusion.
• Electrocardiography (ECG): An ECG is used to assess the electrical activity of the heart. It helps identify arrhythmias or conduction disturbances that may put your pet at risk for sudden fainting or cardiac arrest.
• Systemic Blood Pressure Measurement: It is crucial to measure your pet's blood pressure because systemic hypertension (high blood pressure) can cause the heart muscle to thicken, mimicking HCM. Ruling out high blood pressure ensures your pet receives the correct treatment.
• Genetic Testing: For Maine Coons and Ragdolls, DNA tests can determine if a pet carries the known genetic mutations associated with HCM.

As described in a prominent veterinary critical care manual:

"Radiographic cardiomegaly usually is evident when respiratory signs result from feline cardiomyopathy. Cardiogenic pulmonary edema in the cat typically is patchy but distributed diffusely through the lung..."

Echocardiography is the gold standard diagnostic tool, allowing vets to measure heart wall thickness directly.

Treatment options

Treatment for HCM is tailored to the individual pet, depending on whether they are showing active signs of congestive heart failure, are at risk for blood clots, or are currently asymptomatic (subclinical).

First-Line Therapies (Acute and Essential Management)

• Loop Diuretics (e.g., Furosemide): These medications are critical for pets in active congestive heart failure. They help the body eliminate excess fluid from the lungs and chest cavity by increasing urine production.
• Platelet Aggregation Inhibitors (e.g., Clopidogrel, Aspirin): These medications reduce the blood's ability to clot. They are prescribed to pets with significant left atrial enlargement to help prevent the formation of devastating arterial thromboembolisms.

Second-Line Therapies (Long-Term and Adjunctive Management)

• Beta-Adrenergic Blockers (e.g., Atenolol): These drugs slow the heart rate and reduce the oxygen demand on the heart muscle. By slowing the heart, they allow more time for the stiff ventricle to fill with blood between beats.
• Calcium Channel Blockers (e.g., Diltiazem): These medications can help the heart muscle relax and assist in controlling certain rapid heart rhythms.
• Venodilators / Vasodilators (e.g., Nitroglycerin ointment): Used primarily in emergency settings, these medications dilate blood vessels to help redirect fluid away from the lungs and reduce the workload on the failing heart.
• Aldosterone Antagonists (e.g., Spironolactone): This potassium-sparing diuretic provides mild fluid control and helps prevent the progressive scarring (fibrosis) of the heart muscle.

Prognosis

The prognosis for pets with HCM is highly variable. For pets diagnosed in the subclinical phase (before any symptoms develop), the disease can often be managed successfully for several years. Many of these pets maintain a high quality of life with regular monitoring and medication.

However, once a pet develops congestive heart failure or experiences a thromboembolic event, the prognosis becomes guarded to poor. In these advanced stages, the median survival time typically ranges from 2 to 6 months up to 1 to 2 years, depending on how well the clinical signs can be controlled with medications. It is important to note that long-term prognosis data for dogs and exotic species like rabbits is extremely limited, and clinical expectations in these species are largely based on feline outcomes.

Prevention

Because HCM is primarily an inherited genetic disorder, there is no way to prevent the disease from developing if a pet has inherited the genetic programming for it. However, proactive measures can prevent the disease from being passed down to future generations and help manage the disease before it becomes an emergency:

• Breed Screening: Breeders of predisposed cats (such as Maine Coons and Ragdolls) should utilize genetic testing to identify carriers of the known mutations. Affected pets should be removed from breeding programs.
• Screening Echocardiograms: For breeds at high risk, annual or biennial echocardiograms starting in young adulthood can detect early, subtle changes in the heart muscle before clinical signs appear.
• Lifestyle Management: Maintaining a healthy weight and providing a balanced diet helps reduce the overall workload on your pet's cardiovascular system.

When to call your vet

Hypertrophic cardiomyopathy can escalate into a life-threatening emergency very quickly. You should contact your veterinarian or seek emergency veterinary care immediately if you notice any of the following red flags:

• Open-mouth breathing or panting (especially in cats)
• A resting respiratory rate that consistently exceeds 40 breaths per minute
• Sudden weakness, collapse, or fainting spells
• Sudden inability to use one or both back legs
• Vocalizing in pain while dragging the hind limbs
• Extremely pale or blue-tinged gums

For specific breeds

If you own a Maine Coon, Ragdoll, American Shorthair, Persian, British Shorthair, Norwegian Forest Cat, Scottish Fold, or Bengal Cat, discuss screening options with your veterinarian. Even if your pet appears completely healthy, a screening echocardiogram or genetic test can provide peace of mind or allow for early intervention that could significantly extend your pet's life.

Sources

• Clinical Echocardiography of the Dog and Cat, p. 201
• Internal Medicine, 5th Edition, p. 179, 181
• Small Animal Critical Care Medicine, 2nd Edition, p. 250, 252